These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 5522133)

  • 41. Prostacyclin in the therapy of peripheral arterial disease.
    Szczeklik A; Gryglewski RJ; Nizankowski R; Szczeklik J; Skawiński S; Głuszko P
    Adv Prostaglandin Thromboxane Res; 1980; 7():687-9. PubMed ID: 6989195
    [No Abstract]   [Full Text] [Related]  

  • 42. [Comparative effect of erychroside and strophanthin on the intensity of coronary blood flow].
    Liubetskaia ZhA; Bezruk PI; Angarskaia MA
    Farmakol Toksikol; 1966; 29(2):180-3. PubMed ID: 6000341
    [No Abstract]   [Full Text] [Related]  

  • 43. Effect of beta 1-adrenoceptor blockade in rats at 5 bar ambient pressure.
    Risberg J; Hordnes C; Stuhr LE; Tyssebotn I
    Undersea Hyperb Med; 1994 Dec; 21(4):371-85. PubMed ID: 8000277
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Tolerance increase of k-strophantin-alpha through d,l-alpha-tocopherol acetate. Clinical studies in patients with decompensated heart diseases].
    Ghabussi P; Krämer KD; Hochrein H
    Arzneimittelforschung; 1974 Feb; 24(2):202-5. PubMed ID: 4406371
    [No Abstract]   [Full Text] [Related]  

  • 45. [Regional blood flow in the cortex and medulla of the kidney measured by double thermocouple method--physiological and pharmacological studies].
    Takahashi I; Hagihara Y
    Nihon Yakurigaku Zasshi; 1969 May; 65(3):228-35. PubMed ID: 5388118
    [No Abstract]   [Full Text] [Related]  

  • 46. Haemodynamic action of thymoxamine (an alpha-adrenergic blocking agent) in occlusive peripheral arterial disease.
    Myers KA; Hobbs JT; Irvine WT
    Cardiovasc Res; 1968 Oct; 2(4):360-6. PubMed ID: 4882442
    [No Abstract]   [Full Text] [Related]  

  • 47. [Behavior of the renal and portal flow in conditions of hypotension due to acute hypovolemia during penthranic anesthesia. Experimental contribution].
    Pannacciulli E; Biglioli P; Albonico C; Trazzi R
    G Ital Mal Torace; 1967; 21(6):143-54. PubMed ID: 5616753
    [No Abstract]   [Full Text] [Related]  

  • 48. Whole body and regional hemodynamic effects of minoxidil in the conscious dog.
    Humphrey SJ; Zins GR
    J Cardiovasc Pharmacol; 1984; 6(6):979-88. PubMed ID: 6084789
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of combined use of sildenafil citrate (Viagra) and 17beta-estradiol on ovine coronary and uterine hemodynamics.
    Zoma WD; Baker RS; Clark KE
    Am J Obstet Gynecol; 2004 May; 190(5):1291-7. PubMed ID: 15167832
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Effect of oxyfedrine on the blood flow of coronary vessels in intra- and extramural regions (studies on the dog)].
    Düx A; Hahn N; Felix R; Draznin N; Meuser HJ
    Arzneimittelforschung; 1969 Mar; 19(3):300-4. PubMed ID: 5818776
    [No Abstract]   [Full Text] [Related]  

  • 51. Measurement of the post-exercise blood flow in the calf muscle as a means of predicting the benefit of lumbar sympathectomy in obliterating arterial disease.
    Hirsjärvi E; Karppinen V
    Scand J Clin Lab Invest Suppl; 1967; 100():89. PubMed ID: 6038161
    [No Abstract]   [Full Text] [Related]  

  • 52. [Effect of ouabagenin on the hemodynamics of the dog heart in a closed thorax].
    Simon H; Fricke G; Turina M; Noseda G; Krayenbühl HP; Lüthy E
    Arzneimittelforschung; 1969 May; 19(5):693-7. PubMed ID: 5819775
    [No Abstract]   [Full Text] [Related]  

  • 53. [Bathmotropic action of strophantin].
    Buttseva TA
    Biull Eksp Biol Med; 1966 Dec; 62(12):67-9. PubMed ID: 6005427
    [No Abstract]   [Full Text] [Related]  

  • 54. Effect of digoxin and strophanthin on renal blood flow and systemic blood pressure in normal and bled dogs.
    Hassan AB; Atef M; Shihata IM
    Zentralbl Veterinarmed A; 1979 Feb; 26(2):152-8. PubMed ID: 108876
    [No Abstract]   [Full Text] [Related]  

  • 55. [Hypotensive action of DL-(methylene-3-4) phenyl 2 hydroxy-2-acetamidine hydrocloride (LL-1418)].
    Duteil J; Sautai M; Pessonnier A; Gombert R; Assous E
    Therapie; 1969; 24(4):723-33. PubMed ID: 5822010
    [No Abstract]   [Full Text] [Related]  

  • 56. [Results of thrombolytic therapy of chronic arterial obstructions in the extremities].
    Heinrich F; Schmutzler R
    Dtsch Med J; 1972 May; 23(5):351-8. PubMed ID: 5036947
    [No Abstract]   [Full Text] [Related]  

  • 57. [Therapy of chronic arterial occlusion of the extremities using ergometric exercise and simultaneous intra-arterial administration of energy rich phosphates].
    Alexander K; Wittenborg A; Liegmann B; Hundeshagen H; Fabel H; Tägder K
    Vasa; 1972; 1(2):113-9. PubMed ID: 5031063
    [No Abstract]   [Full Text] [Related]  

  • 58. [Rheographic study of nicergolin in the circulation of the lower limbs in healthy and arteriopathic subjects].
    Boismare F; Philippe JC; Leduc X
    Therapie; 1974; 29(6):925-32. PubMed ID: 4618389
    [No Abstract]   [Full Text] [Related]  

  • 59. [Pharmacodynamic effect of chelating agents on the peripheral and renal circulation of persons with healthy blood vessels and with vascular diseases].
    Hackel F; Graubitz M
    Z Gesamte Inn Med; 1969 Nov; 24(21):761-6. PubMed ID: 4983476
    [No Abstract]   [Full Text] [Related]  

  • 60. [Prognosis of chronic arterial occlusion in the extremities].
    Fischer H; Hårlen H; Hess H
    Lebensversicher Med; 1972 Nov; 24(6):132-6. PubMed ID: 4404528
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.